Article
Exploring the Potential of CPA4 Knockdown as a Prognostic Biomarker in Inhibiting Endometrial Cancer Proliferation
2024-04-19
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>The rise in endometrial cancer rates globally calls for advanced diagnostic methods and new biomarkers. CPA4, known for its role in cancer development, has not yet been studied in relation to endometrial cancer, making it a promising research avenue. <bold>Methods: </bold>We analyzed CPA4's mRNA expression using data from TCGA and GEO databases and validated the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f026db48-7069-5db9-a5fe-2ffe4e991f38
- DOI
- 10.21203/rs.3.rs-4239097/v1
